Pin1 Interacts with the Epstein-Barr Virus DNA Polymerase Catalytic Subunit and Regulates Viral DNA Replication

Journal of Virology

Volumn 87, Issue 4, 2013, Pages 2120-2127

  Narita, Yohei ^a,c   Murata, Takayuki ^a   Ryo, Akihide ^b   Kawashima, Daisuke ^a   Sugimoto, Atsuko ^a,c   Kanda, Teru ^a   Kimura, Hiroshi ^a,c   Tsurumi, Tatsuya ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA POLYMERASE; MITOGEN ACTIVATED PROTEIN KINASE; PEPTIDYLPROLYL ISOMERASE PIN1; PHOSPHOPROTEIN PHOSPHATASE; VIRUS DNA;

ARTICLE; BINDING AFFINITY; BINDING SITE; CATALYSIS; CONTROLLED STUDY; DNA REPLICATION; EPSTEIN BARR VIRUS; GENE DISRUPTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; SITE DIRECTED MUTAGENESIS; VIRUS RECOMBINANT;

CELL LINE; CENTRIFUGATION; DNA MUTATIONAL ANALYSIS; DNA, VIRAL; DNA-BINDING PROTEINS; DNA-DIRECTED DNA POLYMERASE; GENE KNOCKDOWN TECHNIQUES; HERPESVIRUS 4, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOPRECIPITATION; PEPTIDYLPROLYL ISOMERASE; PHOSPHORYLATION; PROTEIN INTERACTION MAPPING; THREONINE; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84873879607     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02634-12     Document Type: Article

References (48)

1. Tsurumi T, Fujita M, Kudoh A. 2005. Latent and lytic Epstein-Barr virus replication strategies. Rev. Med. Virol. 15:3-15.
2. Feng WH, Cohen JI, Fischer S, Li L, Sneller M, Goldbach-Mansky R, Raab-Traub N, Delecluse HJ, Kenney SC. 2004. Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate- associated lymphomas. J. Natl. Cancer Inst. 96:1691-1702.
3. Joab I, Nicolas JC, Schwaab G, de-The G, Clausse B, Perricaudet M, Zeng Y. 1991. Detection of anti-Epstein-Barr-virus transactivator (ZEBRA) antibodies in sera from patients with nasopharyngeal carcinoma. Int. J. Cancer 48:647-649.
4. Daikoku T, Kudoh A, Fujita M, Sugaya Y, Isomura H, Shirata N, Tsurumi T. 2005. Architecture of replication compartments formed during Epstein-Barr virus lytic replication. J. Virol. 79:3409-3418.
5. Fixman ED, Hayward GS, Hayward SD. 1995. Replication of Epstein- Barr virus oriLyt: lack of a dedicated virally encoded origin-binding protein and dependence on Zta in cotransfection assays. J. Virol. 69:2998-3006.
6. Tsurumi T, Daikoku T, Nishiyama Y. 1994. Further characterization of the interaction between the Epstein-Barr virus DNA polymerase catalytic subunit and its accessory subunit with regard to the 3=-to-5= exonucleolytic activity and stability of initiation complex at primer terminus. J. Virol. 68:3354-3363.
7. Tsurumi T. 1993. Purification and characterization of the DNA-binding activity of the Epstein-Barr virus DNA polymerase accessory protein BMRF1 gene products, as expressed in insect cells by using the baculovirus system. J. Virol. 67:1681-1687.
8. Bernad A, Blanco L, Lazaro JM, Martin G, Salas M. 1989. A conserved 3=-5= exonuclease active site in prokaryotic and eukaryotic DNA polymerases. Cell 59:219-228.
9. Bernad A, Zaballos A, Salas M, Blanco L. 1987. Structural and functional relationships between prokaryotic and eukaryotic DNA polymerases. EMBO J. 6:4219-4225.
10. Ryo A, Nakamura M, Wulf G, Liou YC, Lu KP. 2001. Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC. Nat. Cell Biol. 3:793-801.
11. Lu KP, Zhou XZ. 2007. The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease. Nat. Rev. Mol. Cell Biol. 8:904-916.
12. Liou YC, Zhou XZ, Lu KP. 2011. Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins. Trends Biochem. Sci. 36:501-514.
13. Nakamura K, Greenwood A, Binder L, Bigio EH, Denial S, Nicholson L, Zhou XZ, Lu KP. 2012. Proline isomer-specific antibodies reveal the early pathogenic tau conformation in Alzheimer's disease. Cell 149:232-244.
14. Wulf G, Finn G, Suizu F, Lu KP. 2005. Phosphorylation-specific prolyl isomerization: is there an underlying theme? Nat. Cell Biol. 7:435-441. 15. Yeh ES, Means AR. 2007. PIN1, the cell cycle and cancer. Nat. Rev. Cancer 7:381-388.
15. Yeh ES, Means AR. 2007. PIN1, the cell cycle and cancer. Nat. Rev. Cancer 7:381-388.
16. Winkler KE, Swenson KI, Kornbluth S, Means AR. 2000. Requirement of the prolyl isomerase Pin1 for the replication checkpoint. Science 287: 1644-1647.
17. Lu KP. 2004. Pinning down cell signaling, cancer and Alzheimer's disease. Trends Biochem. Sci. 29:200-209.
18. Tun-Kyi A, Finn G, Greenwood A, Nowak M, Lee TH, Asara JM, Tsokos GC, Fitzgerald K, Israel E, Li X, Exley M, Nicholson LK, Lu KP. 2011. Essential role for the prolyl isomerase Pin1 in Toll-like receptor signaling and type I interferon-mediated immunity. Nat. Immunol. 12: 733-741.
19. Ayala G, Wang D, Wulf G, Frolov A, Li R, Sowadski J, Wheeler TM, Lu KP, Bao L. 2003. The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer. Cancer Res. 63:6244-6251.
20. Bao L, Kimzey A, Sauter G, Sowadski JM, Lu KP, Wang DG. 2004. Prevalent overexpression of prolyl isomerase Pin1 in human cancers. Am. J. Pathol. 164:1727-1737.
21. Lee KY, Lee JW, Nam HJ, Shim JH, Song Y, Kang KW. 2011. PI3- kinase/p38 kinase-dependent E2F1 activation is critical for Pin1 induction in tamoxifen-resistant breast cancer cells. Mol. Cells 32:107-111.
22. Suizu F, Ryo A, Wulf G, Lim J, Lu KP. 2006. Pin1 regulates centrosome duplication, and its overexpression induces centrosome amplification, chromosome instability, and oncogenesis. Mol. Cell. Biol. 26:1463-1479.
23. Ryo A, Liou YC, Wulf G, Nakamura M, Lee SW, Lu KP. 2002. PIN1 is an E2F target gene essential for Neu/Ras-induced transformation of mammary epithelial cells. Mol. Cell. Biol. 22:5281-5295.
24. Wulf G, Garg P, Liou YC, Iglehart D, Lu KP. 2004. Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis. EMBO J. 23:3397-3407.
25. Takahashi K, Akiyama H, Shimazaki K, Uchida C, Akiyama-Okunuki H, Tomita M, Fukumoto M, Uchida T. 2007. Ablation of a peptidyl prolyl isomerase Pin1 from p53-null mice accelerated thymic hyperplasia by increasing the level of the intracellular form of Notch1. Oncogene 26: 3835-3845.
26. Gershburg E, Hong K, Pagano JS. 2004. Effects of maribavir and selected indolocarbazoles on Epstein-Barr virus protein kinase BGLF4 and on viral lytic replication. Antimicrob. Agents Chemother. 48:1900-1903.
27. Wang FZ, Roy D, Gershburg E, Whitehurst CB, Dittmer DP, Pagano JS. 2009. Maribavir inhibits Epstein-Barr virus transcription in addition to viral DNA replication. J. Virol. 83:12108-12117.
28. Murata T, Isomura H, Yamashita Y, Toyama S, Sato Y, Nakayama S, Kudoh A, Iwahori S, Kanda T, Tsurumi T. 2009. Efficient production of infectious viruses requires enzymatic activity of Epstein-Barr virus protein kinase. Virology 389:75-81.
29. Noda C, Murata T, Kanda T, Yoshiyama H, Sugimoto A, Kawashima D, Saito S, Isomura H, Tsurumi T. 2011. Identification and characterization of CCAAT enhancer-binding protein (C/EBP) as a transcriptional activator for Epstein-Barr virus oncogene latent membrane protein 1. J. Biol. Chem. 286:42524-42533.
30. Delecluse HJ, Hilsendegen T, Pich D, Zeidler R, Hammerschmidt W. 1998. Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc. Natl. Acad. Sci. U. S. A. 95:8245-8250.
31. Isomura H, Stinski MF, Kudoh A, Murata T, Nakayama S, Sato Y, Iwahori S, Tsurumi T. 2008. Noncanonical TATA sequence in the UL44 late promoter of human cytomegalovirus is required for the accumulation of late viral transcripts. J. Virol. 82:1638-1646.
32. Palancade B, Marshall NF, Tremeau-Bravard A, Bensaude O, Dahmus ME, Dubois MF. 2004. Dephosphorylation of RNA polymerase II by CTD-phosphatase FCP1 is inhibited by phospho-CTD associating proteins. J. Mol. Biol. 335:415-424.
33. Xu YX, Hirose Y, Zhou XZ, Lu KP, Manley JL. 2003. Pin1 modulates the structure and function of human RNA polymerase II. Genes Dev. 17: 2765-2776.
34. Xu YX, Manley JL. 2007. Pin1 modulates RNA polymerase II activity during the transcription cycle. Genes Dev. 21:2950-2962.
35. Liao Y, Wei Y, Zhou X, Yang JY, Dai C, Chen YJ, Agarwal NK, Sarbassov D, Shi D, Yu D, Hung MC. 2009. Peptidyl-prolyl cis/trans isomerase Pin1 is critical for the regulation of PKB/Akt stability and activation phosphorylation. Oncogene 28:2436-2445.
36. Pulikkan JA, Dengler V, Peer Zada AA, Kawasaki A, Geletu M, Pasalic Z, Bohlander SK, Ryo A, Tenen DG, Behre G. 2010. Elevated PIN1 expression by C/EBPα-p30 blocks C/EBPα-induced granulocytic differentiation through c-Jun in AML. Leukemia 24:914-923.
37. Wulf GM, Ryo A, Wulf GG, Lee SW, Niu T, Petkova V, Lu KP. 2001. Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1.EMBOJ. 20:3459-3472.
38. Ryo A, Suizu F, Yoshida Y, Perrem K, Liou YC, Wulf G, Rottapel R, Yamaoka S, Lu KP. 2003. Regulation of NF-B signaling by Pin1- dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol. Cell 12:1413-1426.
39. Milbradt J, Webel R, Auerochs S, Sticht H, Marschall M. 2010. Novel mode of phosphorylation-triggered reorganization of the nuclear lamina during nuclear egress of human cytomegalovirus. J. Biol. Chem. 285: 13979-13989.
40. Peloponese JM, Jr, Yasunaga J, Kinjo T, Watashi K, Jeang KT. 2009. Peptidylproline cis-trans-isomerase Pin1 interacts with human T-cell leukemia virus type 1 Tax and modulates its activation of NF-B. J. Virol. 83:3238-3248.
41. Jeong SJ, Ryo A, Yamamoto N. 2009. The prolyl isomerase Pin1 stabilizes the human T-cell leukemia virus type 1 (HTLV-1) Tax oncoprotein and promotes malignant transformation. Biochem. Biophys. Res. Commun. 381:294-299.
42. Pang R, Lee TK, Poon RT, Fan ST, Wong KB, Kwong YL, Tse E. 2007. Pin1 interacts with a specific serine-proline motif of hepatitis B virus Xprotein to enhance hepatocarcinogenesis. Gastroenterology 132:1088-1103.
43. Lim YS, Tran HT, Park SJ, Yim SA, Hwang SB. 2011. Peptidyl-prolyl isomerase Pin1 is a cellular factor required for hepatitis C virus propagation. J. Virol. 85:8777-8788.
44. + Tlymphocytes. Nat. Med. 16:329-333.
45. Misumi S, Inoue M, Dochi T, Kishimoto N, Hasegawa N, Takamune N, Shoji S. 2010. Uncoating of human immunodeficiency virus type 1 requires prolyl isomerase Pin1. J. Biol. Chem. 285:25185-25195.
46. Kojima Y, Ryo A. 2010. Pinning down viral proteins: a new prototype for virus-host cell interaction. Front. Microbiol. 1:107. doi:10.3389/fmicb .2010.00107.
47. Ryo A, Liou YC, Lu KP, Wulf G. 2003. Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer. J. Cell Sci. 116:773-783.
48. Ryo A, Uemura H, Ishiguro H, Saitoh T, Yamaguchi A, Perrem K, Kubota Y, Lu KP, Aoki I. 2005. Stable suppression of tumorigenicity by Pin1-targeted RNA interference in prostate cancer. Clin. Cancer Res. 11: 7523-7531.